January 15, 2026 - 20:45

The recent surge in the stock market, coupled with an increase in deal-making activity, has led to impressive profit growth for two of Wall Street's leading investment banks. In the fourth quarter, both firms reported double-digit increases in their earnings, highlighting their strong performance amid a favorable economic climate.
Goldman Sachs reported a 12% increase in net earnings, reaching $4.62 billion, which translates to a profit of $14.01 per share. This marks a significant improvement compared to the same period last year, showcasing the bank's ability to capitalize on market conditions.
Similarly, Morgan Stanley also experienced robust growth, with earnings rising to $4.4 billion, or $2.68 per share. This represents a substantial increase from the previous year when the bank reported a profit of $3.71 billion, or $2.22 per share.
The strong financial results from these major banks reflect not only their resilience but also the overall health of the financial markets, setting a positive tone for the industry moving forward.
May 31, 2026 - 03:22
Why a Fund Made a $143 Million Bet on Indivior With Shares Up a Staggering 200%A single investment fund has placed a staggering $143 million wager on Indivior, a pharmaceutical company whose shares have skyrocketed roughly 200% over the past year. The bold move comes as the...
May 30, 2026 - 04:48
Citizens Financial Group Links Rhode Island Training Push To Long Term StoryCitizens Financial Group has announced new community investments in Rhode Island that focus on workforce development and financial education. The company introduced a statewide Banking...
May 29, 2026 - 18:50
Was Trump's investment in a sushi restaurant a mistake? Why some financial experts say Trump’s trades smell fishyA recent investment by former President Donald Trump has sparked confusion and criticism from financial experts, who are questioning whether the move was a costly error. Trump reportedly put money...
May 29, 2026 - 00:56
VERAXA Biotech Secures $27.5M Financing, to Go Public Via SPACSwiss biotech firm VERAXA Biotech AG has secured a significant financial commitment as it prepares to list on the Nasdaq. The company announced it has entered into a securities purchase agreement...